MUC5AC and neoplasm: In the field of precision oncology, the belief that aberrant mucin-type O-glycosylation is a key factor in the complex molecular structural alterations of tumors highlights the potential of using mucin-type O-glycans as tumor-specific therapeutic targets and biomarkers.